CHU Bordeaux
Bordeaux, France
Completed
NCT Number: NCT05546801
Antenatal Ultrasound Diagnosis of Periventricular Pseudocysts and Postnatal Outcome
The present study aims to improve the information given to the parents during the screening of periventricular pseudocysts in the Pluridisciplinary Center of Prenatal Diagnosis, with retrospective cases screened during the last 5 years in university hospital of Bordeaux.
Completed
Looking for future studies?
Notify MeKey information
Conditions
Age range
0 year–5 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
About this study
Antenatal ultrasound screening for periventricular pseudocysts is steadily increasing, enabled in part by technological advances in ultrasound equipment.
Most of studies dealing with periventricular pseudocysts and subsequent neurodevelopment are based on neonatal screening, mostly performed in neonatal units.
Current data in the literature on the postnatal outcome of children screened antenatally are scarce; there are only 5 cohort studies with small numbers on the subject.
The present study aims to improve the information given to the parents during the screening of periventricular pseudocysts in the Pluridisciplinary Center of Prenatal Diagnosis, with retrospective cases screened during the last 5 years in university hospital of Bordeaux.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Adult patient diagnosed with a periventricular cyst during a prenatal ultrasound at Bordeaux University Hospital between January 1, 2016 and December 31, 2020.
- Patient affiliated with or benefiting from a social security plan.
- Oral informed consent.
Exclusion criteria
- Subarachnoid cyst
- Blake's pouch cyst
- Choroid plexus cyst
- Periventricular leukomalacia
- Poor understanding of French
- Patient under legal protection.
Treatment and study plan
Questionnaire
Otherquestionnaire on postnatal development
Primary outcomes
-
postnatal child development
Time frame: Baseline
composite criterion as follows: Delayed acquisition is defined according to the standards of the Pediatric Society: age of sitting > 8 months, age of walking > 18 months, ability or not to associate 3 words at age 3. The use of a medical profession concerns follow-up by a speech therapist, a psychomotrician or a physiotherapist. It is not necessarily a periodic follow-up but a minimum of 2 consultations after the "assessment" consultation.
The scoring defines 2 groups,
- children with 0 points considered with a "normal" post-natal development
- children with 1 point or more considered with a post-natal development disorder.
Secondary outcomes
-
mother's medical history
Time frame: Baseline
mother's medical history
-
medical history of the child
Time frame: Baseline
medical history of the child
Sponsors and collaborators
Lead sponsor
University Hospital, Bordeaux
Other
Registry information
Acronym: UDiPPP
Important dates
- Study start
- 2022
- Primary completion
- 2022
- Study completion
- 2022
- First posted
- Sep 21, 2022
- Registry last updated
- May 29, 2026
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.